This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Affordable Care Act Kills Obama's Credibility as America's CEO

NEW YORK (TheStreet) -- Thanks to the Affordable Care Act, President Obama has lost credibility as a leader and effective executive with most Americans.

A good CEO must work within the strengths and limitations of his organization,  then execute effectively to deliver on the promises he makes.

Enter the president's signature program:

-- If you can't buy health insurance, the ACA will make it easy to obtain.

-- If you like the insurance you have, the ACA will let you can keep it.

-- If you like your doctor, the ACA will let you keep him.

-- If you already have good insurance, the ACA will make it cheaper.

The ACA Web site, HealthCare.gov, even with many efforts at improvement, is simply not easy to use or adequately effective.

As of Nov. 30, 365,000 Americans signed up for insurance via that Web site and the other exchanges set up by the states. This is well short of the Administration's target, and makes unlikely that seven million will sign up by March 31, as expected by the Department of Health and Human Services.

Many who have failed to participate are young and healthy, and whose participation is needed to make the insurance policies offered viable.

When new insurance policies take effect next year, many Americans who successfully navigated the federal Web site may find they have signed up for nothing at all. Critical data about policyholders, dependents, incomes and the like have not been effectively transmitted to insurance companies for about 1 in 10 applicants. Also, the software needed to pay insurance companies federal subsidies promised for low and moderate income Americans is not yet completed.

Insurance companies won't have enough cash to pay claims. Doctors will be scrambling to collect money directly from patients (who may not be able to pay) to keep their practices solvent.

Right out of the box, the ACA declared many individual and group insurance policies to be inadequate and illegal. After a public uproar, the president declared those policies could be reinstated for one year, but many state insurance commissioners balked at this unworkable reversal. Insurance companies simply can't recreate the risk pools of customers that made those policies viable.

Once out, the jelly could not be put back into the jar.

Across the full range of policies sold directly to individuals and provided groups through employers, insurance companies are eliminating doctors and hospitals from networks to meet arbitrary ObamaCare mandates. Americans are scrambling to find new physicians, who are often overwhelmed and sometimes cannot provide essential services some patients need.

Policies now canceled paid millions of dollars in critical services, including cancer treatments by highly specialized clinics. Now they are being replaced by new contracts that don't pay for those life-saving treatments, yet are cluttered with unneeded benefits, such as pediatric vision services for childless couples in their 50s.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs